Literature DB >> 32454729

Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.

Prabhakar Panzade1, Giridhar Shendarkar1.   

Abstract

OBJECTIVES: Pharmaceutical cocrystals are a promising tool to enhance the solubility and dissolution of poorly soluble drugs. Zaltoprofen (ZFN) is nonsteroidal anti-inflammatory drug with a prevalent solubility problem. The present study was undertaken to enhance the solubility and dissolution of ZFN through pharmaceutical cocrystals by screening various coformers.
MATERIALS AND METHODS: Cocrystals of ZFN were prepared in 1:1 and 1:2 ratio of drug:coformer by the dry grinding method. The melting point and solubility of the crystalline phase were determined. The potential cocrystals were characterized by differential scanning calorimetry (DSC), infrared spectroscopy, and powder X-ray diffraction (PXRD). Cocrystals were subjected to dissolution rate and stability study.
RESULTS: ZFN-nicotinamide (NIC) cocrystals demonstrated deviation in melting point and solubility. The cocrystals were obtained in both 1:1 and 1:2 ratios with NIC. The infrared analysis noticeably indicated the shifting of characteristic bands of ZFN. The crystallinity of the cocrystals was evident from the XRPD pattern and notable difference in the 2θ values of intense peaks. The DSC spectra of the cocrystals exhibited altered endotherms analogous to melting point. The cocrystals showed a faster dissolution rate and a 55% increase in the extent of dissolution compared to pure drug. The cocrystals were stable at room temperature and accelerated conditions.
CONCLUSION: The prepared cocrystals exhibited greater solubility and dissolution compared to the pure drug and were stable at room temperature and accelerated conditions. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Pharmaceutical cocrystal; dissolution; solubility; zaltoprofen

Year:  2019        PMID: 32454729      PMCID: PMC7227948          DOI: 10.4274/tjps.galenos.2018.15013

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  24 in total

Review 1.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 2.  Pharmaceutical co-crystals-an opportunity for drug product enhancement.

Authors:  Inna Miroshnyk; Sabiruddin Mirza; Niklas Sandler
Journal:  Expert Opin Drug Deliv       Date:  2009-04       Impact factor: 6.648

Review 3.  Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.

Authors:  Dipak Dilip Gadade; Sanjay Sudhakar Pekamwar
Journal:  Adv Pharm Bull       Date:  2016-12-22

4.  Molecular salts and co-crystals of mirtazapine with promising physicochemical properties.

Authors:  Anindita Sarkar; Sohrab Rohani
Journal:  J Pharm Biomed Anal       Date:  2015-03-12       Impact factor: 3.935

5.  Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals.

Authors:  Katsuhiko Yamamoto; Shunichirou Tsutsumi; Yukihiro Ikeda
Journal:  Int J Pharm       Date:  2012-07-31       Impact factor: 5.875

6.  Novel furosemide cocrystals and selection of high solubility drug forms.

Authors:  N Rajesh Goud; Swarupa Gangavaram; Kuthuru Suresh; Sharmistha Pal; Sulur G Manjunatha; Sudhir Nambiar; Ashwini Nangia
Journal:  J Pharm Sci       Date:  2011-11-11       Impact factor: 3.534

7.  Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide.

Authors:  Ziyaur Rahman; Cyrus Agarabi; Ahmed S Zidan; Saeed R Khan; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2011-05-20       Impact factor: 3.246

8.  Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.

Authors:  Koji Shiraki; Noriyuki Takata; Ryusuke Takano; Yoshiki Hayashi; Katsuhide Terada
Journal:  Pharm Res       Date:  2008-07-24       Impact factor: 4.200

9.  Pharmaceutical Cocrystals and Their Physicochemical Properties.

Authors:  Nate Schultheiss; Ann Newman
Journal:  Cryst Growth Des       Date:  2009-04-20       Impact factor: 4.076

10.  Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.

Authors:  Prabhakar Panzade; Giridhar Shendarkar; Sarfaraj Shaikh; Pavan Balmukund Rathi
Journal:  Adv Pharm Bull       Date:  2017-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.